$0.449
+0.025 (+5.65%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ONCY Prediction & Forecast by Similar Chart Analysis
Alphio's ONCY stock price prediction model matches the current Oncolytics Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.43 (-1.17%). The 1-week path is $0.44 (-0.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Oncolytics Biotech Inc Stock?
Oncolytics Biotech Inc is not a good buy right now due to its current price of $0.40, which is significantly below its 52-week high of $1.30, indicating a substantial decline in value. Additionally, the company's RSI is at a very low 12.234, suggesting it is oversold and may continue to face downward pressure. The forward P/E ratio of 45.45 indicates high expectations for future earnings that may not materialize given the company's ongoing losses, with net income consistently negative, such as -12,679,060.40 USD in Q1 2026. The main risk is the company's cash position, which is only $5.49 million, insufficient to sustain operations for the next 12 months, raising doubts about its viability.
ONCY stock price ended at $0.45 on Thursday, after rising +5.65%
Oncolytics Biotech Inc (ONCY) last closed at $0.4394, losing -2.09%. These facts feed the 1-day and 1-week ONCY price prediction above.
Forecast Drivers
Oncolytics Biotech Inc (ONCY) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ONCY, ranked by similarity.
Seasonality analysis for ONCY
Historically the probability of a positive November return for ONCY is 43.18%. November offers the highest probability of a positive month at 43.18%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ONCY
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.05 | $1.13 | $1.37 | +157.96% |
| Dec 2026 | $1.09 | $1.39 | $1.63 | +216.50% |
In 2026, Oncolytics Biotech Inc (ONCY) is projected to range from $1.05 to $1.63.
Oncolytics Biotech Inc 2026 monthly forecast
In Nov 2026, Oncolytics Biotech Inc is projected to average $1.13, with a low of $1.05 and high of $1.37.
In Dec 2026, Oncolytics Biotech Inc is projected to average $1.39, with a low of $1.09 and high of $1.63.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.